Wearable devices such as smart watches could be used to detect a higher risk of developing heart failure and irregular heart rhythms in later life, a new study led by UCL researchers suggests.
The peer-reviewed study, published in The European Heart Journal – Digital Health, analysed data from 83,000 people who had undergone a 15-second electrocardiogram (ECG) comparable to the kind carried out using smart watches and phone devices.
The researchers identified ECG recordings containing extra heart beats which are usually benign but, where they occur frequently, are linked to conditions such as heart failure and arrhythmia.
The researchers found that people with an extra beat in this short recording (one in 25 of the total) had a twofold risk of developing heart failure or an irregular heart rhythm (atrial fibrillation) over the next 10 years.
The ECG recordings analysed were from people aged between 50 and 70 who had no known cardiovascular disease at the time.
Lead author Dr Michele Orini (UCL Institute of Cardiovascular Science) said:
“Our study suggests that ECGs from consumer-grade wearable devices may help with detecting and preventing future heart disease.
“The next step is to investigate how screening people using wearables might best work in practice.
“Such screening could potentially be combined with the use of artificial intelligence and other computer tools to quickly identify the ECGs indicating higher risk, as we did in our study, leading to a more accurate assessment of risk in the population and helping to reduce the burden of these diseases.”
In an ECG, sensors attached to the skin are used to detect the electrical signals produced by the heart every time it beats.
In clinical settings, at least 10 sensors are placed around the body and the recordings are assessed at by a specialist doctor to see if there are signs of a possible problem.
Consumer-grade wearable devices rely on two sensors (single-lead) embedded in a single device and are less cumbersome as a result but may also be less accurate.
In the new paper, the research team used machine learning and an automated computer tool to identify recordings with extra beats.
The extra beats were classed as either premature ventricular contractions (PVCs), coming from the lower chambers of the heart, or premature atrial contractions (PACs), coming from the upper chambers.
The recordings identified as having extra beats, and some recordings that were not judged to have extra beats, were then reviewed by two experts to ensure that the classification was correct.
The researchers first looked at data from 54,016 participants of the UK Biobank project with a median age of 58, whose health was tracked for an average of 11.5 years following the recording of their ECG. T
hey then looked at a second group of 29,324 participants, with a median age of 64, who were followed-up for 3.5 years.
After adjusting for potentially confounding factors such as age and medication use, the researchers found that an extra beat coming from the lower chambers of the heart was linked to a twofold increase in later heart failure, while an extra beat from the top chambers (atria) was linked to a twofold increase in cases of atrial fibrillation (AF).
Senior author Professor Pier D. Lambiase (UCL Institute of Cardiovascular Science and Barts Heart Centre, Barts NHS Health Trust) said:
“Being able to identify people at risk of heart failure and arrhythmia at an early stage would mean we could assess higher-risk cases more effectively and help to prevent cases by starting treatment early and providing lifestyle advice about the importance of regular, moderate exercise and diet.”
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
Urgent work needed to tackle ‘substantial’ digital health inequality
eSight: “The technology has the potential to change someone’s life”
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
- News3 weeks ago
Why a leading healthcare CEO sees recombinant DNA as a metaphor for developing breakthrough technologies
- AI6 days ago
AI model predicts breast cancer risk without racial bias
- Medtech4 weeks ago
Surtex Instruments to unveil game-changing Infinex microsurgery instruments at MEDICA
- AI2 weeks ago
Humans make better cancer treatment decisions than AI, study finds